COVID-19 pandemic could increase the global burden of tuberculosis
Before COVID-19, over 4,000 people were dying from TB every day. In countries where health services are strained, there is ...
Boosting host immune defenses to treat tuberculosis
Current treatment regimens for Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, are long, complex, and hard for people to ...
How an AI solution can design new tuberculosis drug regimens
With a shortage of new tuberculosis drugs in the pipeline, a software tool from the University of Michigan can predict ...
Study shows non-TB lung infections rising; more in women and older people
Nontuberculous mycobacteria Mycobacteria are best known for the strains causing leprosy and tuberculosis. However, there are other mycobacteria that do ...
Blood test could detect lung transplant rejection early
Chronic transplant rejection can be deadly, and recognising it as early as possible is key to achieving the best possible ...
How a new tuberculosis drug could stop one of the world’s deadliest diseases
Global disease: a doctor treats a TB prisoner in Jakarta, Indonesia ( EPA ) Tuberculosis struck 10 million people worldwide ...
Tuberculosis: New insights into the pathogen
Tuberculosis is a highly contagious infectious disease that is typically spread through aerosols and mainly affects the lungs. According to ...
Drug tolerant Tuberculosis could soon be tracked using genes
A team of researchers from the Rutgers New Jersey Medical School have found genetic foot prints of tuberculosis bacteria that ...
Why HIV patients are more likely to develop tuberculosis
Tuberculosis and HIV -- two of the world's deadliest infectious diseases -- are far worse when they occur together. Now, ...
Janssen Announces U.S. FDA Accelerated Approval for SIRTURO® (bedaquiline) as Part of Combination Therapy to Treat Adolescents with Pulmonary Multidrug-Resistant Tuberculosis
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has ...
Update of WHO guidelines on the programmatic management of drug-resistant TB
8 August 2019 | Geneva - Drug-resistant TB continues to pose formidable challenges due to the complexity of effective treatment ...
The fight against tuberculosis _ archive, 1913
Tuberculosis patients from St. Thomas’ Hospital rest in their beds in the open air by the River Thames, opposite the ...